Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today [Yahoo! Finance]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Yahoo! Finance
The transaction valued Amicus at $14.50 per share, which represented a 33% premium to its last closing price. The acquisition expanded BioMarin's position as a leader in rare diseases by adding two marketed treatments, Galafold and Pombiliti-Opfolda, to its portfolio. Investors reacted positively as the move was expected to accelerate revenue growth and boost earnings per share within the first year after closing. The deal also received unanimous approval from the boards of directors of both companies, signaling strong support for the merger. The shares closed the day at $61.19, up 17.8% from previous close. Is now the time to buy BioMarin Pharmaceutical? Access our full analysis report here BioMarin Pharmaceutical's shares are not very volatile and have only had 5 moves greater than 5% over the last year. Moves this big are rare for BioMarin Pharmaceutical and indicate this news significantly impacted the market's perception of the business. The previous big move we wrote ab
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More [Yahoo! Finance]Yahoo! Finance
- Biotech Bombshell: BioMarin's $4.8B Bet Ignites Amicus Shares in Rare-Disease Power Play [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical Inc. (BMRN) M&A Call Transcript [Seeking Alpha]Seeking Alpha
- BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping. [Yahoo! Finance]Yahoo! Finance
- BioMarin is Buying a Rare-Disease Biotech for Nearly $5 Billion. The Stock Is Jumping. [Barron's]Barrons
BMRN
Earnings
- 10/27/25 - Miss
BMRN
Sec Filings
- 12/19/25 - Form 8-K
- 12/17/25 - Form 8-K
- 12/2/25 - Form 4
- BMRN's page on the SEC website